Adaptive Arm Training for Children With Hemiplegia
1 other identifier
interventional
20
1 country
1
Brief Summary
The goal of this research is to provide limb training in children with hemiplegia using a bimanual-to-unimanual training approach. Twenty pediatric patients aged 5-17 years with acquired brain injury will receive training on the bimanual-to-unimanual device for a period of 9 weeks. During the training, children use both arms to operate robotic arms to play a video game. We will assess changes in hand impairment after the training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 7, 2017
CompletedFirst Submitted
Initial submission to the registry
December 22, 2017
CompletedFirst Posted
Study publicly available on registry
January 2, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedJanuary 10, 2022
January 1, 2022
5.1 years
December 22, 2017
January 5, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Change in Assisting Hand Assessment
The Assisting Hand Assessment evaluated how effectively children use their hands to complete bimanual tasks.
Before intervention compared to after intervention
Change in Box and Box Test
The Box and Blocks test measures how many blocks a child can move with one hand from one box to another in one minute with the impaired hand.
Before intervention compared to after intervention
Change in range of motion
The robotic device measures range of motion of the shoulder.
Before intervention compared to after intervention
Study Arms (1)
Bimanual Arm Training
EXPERIMENTALChildren in the study will all receive the same treatment, which includes 9 weeks of training on the bimanual arm trainer robotic device.
Interventions
Device-based bimanual-to-unimanual training will be provided with the Bimanual Arm Trainer (BAT, Mirrored Motion Works, NC). The device provides bimanual-to-unimanual training of simultaneous shoulder external rotation and elbow extension, and independent training of pronation-supination and grasp and release of each hand. Range of motion and speed are recorded during training and feedback and motivation are provided through age-appropriate gaming modules.
Eligibility Criteria
You may qualify if:
- Hemiplegia due to brain injury at least 3 months before study enrollment.
You may not qualify if:
- Any social or medical problem that precludes compliance with the protocol.
- Treatment with botulinum toxin or intrathecal baclofen in the 3 months preceding enrollment.
- Implanted neuromodulatory or electronic device or other complicating illness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kathleen M Friel
Hartsdale, New York, 10530, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 22, 2017
First Posted
January 2, 2018
Study Start
November 7, 2017
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
January 10, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- during the study
We plan to share results with our collaborator Dr. Preeti Raghaven, at New York University. Dr. Raghavan created the robot we are using, has IRB approval to use the robot, and is a consultant on this study. Personal health information will not be shared.